Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 162   

Articles published

NVS 74.78 -0.07 (-0.10%)
price chart
Analyst Viewpoints on Price Reaction History: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) soared 0.24% during previous trade, a total of 1.86M shares exchanged hands compared with its average trading volume of 3.16M shares whereas its relative volume is 0.60.
Analysts Review on Price Reaction History: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) soared 0.13% during previous trade, a total of 2.09M shares exchanged hands compared with its average trading volume of 3.17M shares whereas its relative volume is 0.61.
Zacks Rank on Novartis AG (NVS) based on Estimated Earnings  Highland Mirror
Novartis AG (ADR) (NVS) Q3 Earnings: What Leerink Expects
Novartis AG (ADR) (NYSE:NVS) is expected to report its third quarter financial results on October 25. Leerink Partners analyst Seamus Fernandez expects data to be broadly in line with his estimates and consensus.
Stocks To Watch For- Gap Inc (NYSE:GPS), Novartis AG (ADR) (NYSE:NVS)
Gap Inc (NYSE:GPS) traded at a yearly high level of $30.74 during the last trading session. The last session's volume of 3.50 million shares was lower than its average volume of 5.41 million shares.
Novartis AG (ADR) (NYSE:NVS) Breast Cancer Drug Approved by the FDA to Compete ...
Novartis AG (ADR) (NYSE:NVS) has said that Kisqali, a drug which when combined with letrozole is used for the treatment of breast cancer, has received the approval of the Food and Drug Administration.
Stock Movers- Novartis AG (ADR) (NYSE:NVS), Norfolk Southern Corp. (NYSE:NSC)  Wall Street Times (press release)
Analysts' Recommendations Stocks Buzz: AbbVie Inc (NYSE:ABBV) & Novartis AG ...
On Tuesday, Shares of AbbVie Inc (NYSE:ABBV) lost -0.18% to $65.98. The share price is trading in a range of $65.64 - 66.21. The stock exchanged hands with 5.07 million shares contrast to its average daily volume of 7.02 million shares.
Analyst Review Alert on Price Target: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) plunged -1.50% during previous trade, a total of 5.42M shares exchanged hands compared with its average trading volume of 3.39M shares whereas its relative volume is 1.96.
Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face ...
Last year, Novartis AG (ADR) (NYSE:NVS) entered into pay-for-performance agreements for its Entresto heart failure drug.
Large Buying Action and Inflow of Money Witnessed in Novartis AG (NVS)  Highland Mirror
Novartis AG (NVS) Seeks M&A as It Mulls Possible Alcon Sale
Novartis AG (ADR) (NYSE:NVS) is planning to enter into mergers and acquisitions as it continues to weigh options for the long-struggling eye-care business Alcon.
Analyst Views on Price Target: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) plunged -0.57% during previous trade, a total of 7.41M shares exchanged hands compared with its average trading volume of 3.15M shares whereas its relative volume is 2.25.